OGEN Oragenics
- 0.3260
- +0.0011+0.34%
- 0.3200
- -0.0060-1.84%
Oragenics News
Oragenics | 4: Statement of changes in beneficial ownership of securities-Officer Huffman Janet
Oragenics | 4: Statement of changes in beneficial ownership of securities-Officer REDMOND J MICHAEL
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director POPE CHARLES L
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director GANDOLFO JOHN P
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director DUNTON ALAN W
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director KOSKI ROBERT C
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Cassidy Bruce A. Sr.
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Murphy Kimberly M
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Telling Fred
Oragenics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Richard Abbe(9.99%),Iroquois Capital Management L.L.C.(7.0%), etc.
Oragenics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.9%),Lind Global Partners II LLC(5.9%), etc.
Oragenics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Odyssey Health, Inc.(16.6%)
Oragenics | 5: Annual statement of changes in beneficial ownership of securities-Director KOSKI ROBERT C
Oragenics | 4: Statement of changes in beneficial ownership of securities-Officer REDMOND J MICHAEL
Oragenics | 3: Initial statement of beneficial ownership of securities-Officer REDMOND J MICHAEL
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Telling Fred
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director GANDOLFO JOHN P
Oragenics | 4: Statement of changes in beneficial ownership of securities-Director Cassidy Bruce A. Sr.
Oragenics | 3: Initial statement of beneficial ownership of securities-Director GANDOLFO JOHN P
Oragenics | 3: Initial statement of beneficial ownership of securities-Director Cassidy Bruce A. Sr.
Analysis
Price Target
No Data
No Data